LI Dong-wei, DOU De-qiang. Research Advances in Using Ginseng to Prevent and Treat Parkinson’s Disease[J]. ACTA NEUROPHARMACOLOGICA, 2011, 1(4): 55-64.
1 Aarsland D,Londos E,Ballard C.Parkinson's disease dementia and dementia with Lewy bodies: different aspects of one entity[J].Int Psychogeriatr,2009,21(2):216-219.2 Jeff M.Bronstein,Michele Tagliati,Ron L Andres,et al.Deep brain stimulation for Parkinson's disease: an expert consensus and review of key issues [J].Arch Neurol,2011,68(2):165.3 焦玥,王丹巧,王巍.中医药治疗帕金森病的研究进展[J].中国中医基础医学杂志,2008,14(11):875-877.4 Thomas J.Kryzak,John W.Sperling,Cathy D Schleck,et al.Hemiarthroplasty for proximal humerus fractures in patients with Parkinson’s disease[J].Clinical Orthopedics and Related Research,2010,468(7):1817-1821.5 孙一奎.赤水玄珠[M].明.清文渊阁四库全書本.6 高鼓峰.西塘感症(中)[M]// 高鼓峰.医宗己任编.北京:学苑出版社,2011:卷七.7 贾治伟.中医药治疗帕金森病的研究进展[J].内蒙古中医药,2003,4:34-35.8 周厚广,鲍远程.中医药治疗帕金森病的研究进展[J].中西医结合心脑血管病杂志,2004,2(10):593-596.9 蒋英.针刺治疗震颤性麻痹19例[J].四川中医,2000,18(9):56.10 冉茂东,郭蕴屏.头针配合体针治疗帕金森氏病36例[J].中国针灸,2000,20(9):544.11 王媛媛,孙红梅,和欣,等.针刺百会和大椎穴对帕金森病小鼠多巴胺能神经元的保护作用 [J].解剖学进展,2010,16(1):16-20.12 吴凌云.颤三针为主治疗帕金森病的临床与实验研究[D].广州:广州中医药大学,2006.13 王彤宇,刘建杰.帕金森病的治疗进展[J].医学综述,2009,15(15):2327-2331.14 谭玉燕,陈生弟.帕金森病多巴胺替代治疗并发的多巴胺失调综合征[J].临床神经病学杂志,2010,23(5):396-397.15 Ceravolo R,Frosini D,Rossi C,et al.Impulse control disorders in Parkinson's disease:definition,epidemiology,risk factors,neurobiology and management [J].Parkinsonism Related Disorders,2009,15(Suppl 4):111-115.16 Deep-Brain Stimulation for Parkinson’s Disease Study Group.Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson’s disease[J]. N Engl J Med,2001,345(13):956-963.17 Betchen SS,Kaplitt M.Future and current surgical therapies in Parkinson’s disease[J].Curr Opin Neurol,2003,16(4):487-493.18 国家药典委员会.中华人民共和国药典(一部)[M].北京:化学工业出版社,2010.19 张登本.神农本草经卷二[M]// 全注全译神农本草经.第一版.北京:新世界出版社,2009:17-18.20 寇宗奭. 本草衍義[M].宋.清光绪十万卷楼叢書本.21 朱震亨. 丹溪先生心法[M].元.明弘治刻本.22 危亦林.世医得效方[M].元.清文渊阁四库全書本.23 朱棣.普济方[M].明.清文渊阁四库全書本.24 王肯堂.证治准绳[M].明.清文渊阁四库全書本.25 潘楫.医灯续焰[M].清.清顺治潘氏陸地舟刻本.26 KW Oh,HS Kim,GC Wagner.Ginseng total saponin inhibits the dopaminergic depletions induced by methamphetamine[J].Planta Med,1997,63(1):80-81.27 王莎莉,李英搏,王亚平.人参总皂苷在神经干细胞移植治疗帕金森病模型小鼠中的作用[J].中国临床康复,2006,10(41):19-22.28 王莎莉,李英搏,王亚平,等.人参总皂苷对人胚胎神经干细胞增殖及定向诱导为多巴胺能神经元的影响[J].中国中药杂志,2007,32(13):1310-1313.29 胡胜全,余惠旻,刘塔斯,等.人参水提物对β-淀粉样蛋白诱导SH-SY5Y细胞凋亡的保护作用[J].时珍国医国药,2009,20(2):257-259.30 刘晓晖,朱鲲鹏,许立.人参皂苷Rb1的研究进展[J].武警医学院学报,2006,15(1):82-84.31 唐斌,程绪菊,刘江,等.人参皂苷药理作用研究进展[J].西南军医,2005,7(3):45-47.32 杨朝鲜,刘军祥,孙珠蕾,等.人参皂甙Rb1对大鼠脑缺血再灌注时神经元凋亡及Bcl-2和Bax表达的影响[J].四川大学学报(医学版),2008,39(2):214-217.33 沈洪妹,张志军,江山,等.人参皂甙Rb3抗缺血低氧性脑损伤及其机制的研究[J].中国应用生理学杂志,2006,22(3):302-306.34 晋亮.人参皂苷对MPP+诱导PC12细胞损伤的保护作用筛选研究[D]. 扬州:扬州大学,2007.35 邓家刚,郝二伟,郭宏伟,等.老年性痴呆复方用药规律探讨[J].山东中医杂志,2007,26(6):363-365.36 陈大庆,朱烈烈,李永领,等.人参皂甙Rg1对颅脑损伤模型大鼠神经细胞凋亡的影响[J].实用医学杂志,2010,26(1):30-31.37 刘颖,李玺,袁海峰.人参皂甙Rg1促进学习记忆作用研究进展[J].中国中西医结合杂志,2006,26(10):956-960.38 周宜灿,陈晓春,朱元贵,等.人参皂苷Rg1可能通过抗氧化作用来保护帕金森病鼠黑质神经元[J].中国临床药理学与治疗学,2003,8(3):273-277.39 方芳,陈晓春,朱元贵.抗氧化作用可能是人参皂甙Rg1抗细胞凋亡的机制[J].中国临床药理学与治疗学,2002,7(5):412-416.40 赵朝晖,陈晓存,朱元贵,等.人参皂苷Rg1延缓细胞衰老过程中端粒长度和端粒酶活性的变化[J].中国药理学通报,2005,21(1):61-66.41 杨赣军,张建平,李庆耀.人参皂苷 Rg1 对帕金森病模型小鼠室管膜下区神经干细胞的作用[J].四川生理科学杂志,2009,31(1):17-19.42 杨海东,林碧莲.人参皂苷Rg1拮抗MPTP诱导小鼠黑质中铁增高的作用[J].山西医科大学学报,2011,42(1):10-14.43 徐华敏.DMTI的高表达在MES23.5细胞铁聚积中的作用及人参皂苷Rg1的保护作用机制研究[D].青岛:青岛大学,2008.44 王俊,姜宏,谢俊霞.帕金森病黑质内铁聚积的原因及其调控机制 [C]// 中国生理学会张锡钧基金会第十届全国青年优秀生理学学术论文综合摘要.北京,2009,30-31.45 Du Xi-xun, Wang Jun,Jiang Hong, et al.The role of Rg1 in the regulation of iron transporters in the MPTP-induced Parkinson’s disease mice model[J].Acta Physiologica Sinica,2008,60(Suppl 1):146.46 Chen Xiaochun,Zhou Yican,Chen Ying, et al.Ginsenoside Rg1 reduces MPTP- induced substantia nigra neuron loss by suppressing oxidative stress[J]. Acta Pharmacol Sin,2005,26(1):56-62.47 杨海东,姜宏,宋宁,等.人参皂苷 Rg1对MPTP致帕金森病模型小鼠多巴胺能神经元保护作用研究[J].解放军药学学报,2007,23(1):17-21.48 Wolf-Dieter Rausch,Shu Liu,Gabriele Gille,et al.Neuroprotective effects of ginsenosides[J].Acta Neurobiol,2006,66(4):369-375.49 裴正斌,彭国光.MPTP帕金森病小鼠黑质NF-κB的表达及其意义[J].中国神经精神疾病杂志,2006,32(3):279.50 王茜,郑桓,张作凤,等.人参皂甙 Rg1 通过 P38 信号通路影响帕金森病 MPTP 模型小鼠黑质COX-2的表达[J].南方医科大学学报,2008,28(9):1594-1598.51 王茜,张宇新,张作凤.核因子NF-κB对帕金森病MPTP模型小鼠黑质COX-2表达的影响[J].第四军医大学学报,2008,29(19):1757-1760.52 徐丽,张敏,陈文芳.人参皂苷 Rg1对多巴胺能神经元的保护作用及 ICI182,780的阻断作用[J].山西医科大学学报,2007,38(8):677-681.53 葛科立.人参皂昔Rg1通过激活P13K/Akt与ERK信号通路对抗6-OHDA的毒性作用[D].青岛:青岛大学,2009.54 刘江,李冉,刘丽娜,等.JNK通路介导帕金森病小鼠黑质神经元丢失及人参皂甙Rg1的保护作用[J].现代预防医学,2008,35(10):1973-1975.55 王永生,李会,张宇新,等.人参皂苷 Rg1对 MPTP所致亚急性帕金森病模型小鼠中脑黒质p-c-Jun与COX-2表达的影响[J].神经解剖学杂志,2009,25(4):432-436.56 Shim InSop,Javaid JI,Kim SangEun.Effect of ginseng total saponin on extracellular dopamine release elicited by local infusion of nicotine into the striatum of freely moving rats[J].Planta Med,2000,66(8):705-708.57 徐琲琲.人参皂苷Re对帕金森病模型小鼠脑内多巴胺能神经元的保护作用及机理初探[D].沈阳:沈阳药科大学,2004.58 徐琲琲,曹颖林,张万琴.人参皂苷Re对帕金森病小鼠保护作用—人参皂甙Re抗黑质神经元凋亡的机制初探.中国天然药物,2004,(03):171-175.[J]59 徐琲琲,刘纯青,马涛,等.人参皂苷Re对MPTP致帕金森病模型小鼠多巴胺能神经元的保护作用.沈阳药科大学学报,2005,22(1):36-44.[J]60 Cho WC,Chung WS,Lee SK, et al.Ginsenoside Re of Panax ginseng possesses significant antioxidant and antihyperlipidemic efficacies in streptozotocin-induced diabetic rats[J].Eur J Pharmacol, 2006,550 (1-3):173-179.61 Chen Limin,Zhou Xiaomian,Cao Yinglin,et al.Neuroprotection of ginsenoside Re in cerebral ischemia-reperfusion injury in rats [J].J Asian Nat Prod Res,2008,10 (5) :439-445.62 曹颖林,徐峰,徐成,等.人参皂苷-Re在神经细胞保护中的应用:中国, CN200810010677.8 [P]. 2008-09-03.63 Xu Bei-bei,He Wen-fei,Lu Jin-cai, et al.Effects of ginsenoside Re on the levels of brain monoamines transmitters and serum corticosterone in water immersion-restraint rats[J].Nat Pro Res Dev, 2009,21(5):752-756,786.64 Habig K,Walter M,Poths S,et al.RNA interference of LRRK 2microarray expression analysis of a Parkinson’s disease key player [J].Neurogenetics,2008,9(2) :83-94.65 D.G.Standaent.Neurochemical changes in Parkinson’s disease[M]//E.Ronken,G.J.M.van Scharrenburg.Parkinson’s disease.USA: IOS Press,2002: 17-28.66 Eng K.Tan,Heinz Reichmann.Cause of Parkinson’s disease:genetics,environment and pathogenesis[M]//Anthony H.V. Schapira.Parkinson’s disease.New York :Oxford University Press,2010:5-16.67 荣娟,陈生弟.帕金森病与遗传因素[J].中华老年医学杂志,1999,18(3):180-182.68 Qwen A.Ross,Adam T.Braithwaite,Matthew J.Farrer.Genetics of Parkinson’s disease[M]//Richard Nass,Serge Przdborski.Parkinson’s disease:molecular and therapeutic insights from model systems.New York :Elsevier Academic Press,2008:9-23.69 Du Guiping,Liu Xiang,Chen Xinping,et al.Drosophila histone deacetylase 6 protects dopaminergic neurons against {alpha}-synuclein toxicity by promoting inclusion formation[J].Mol Biol Cell,2010,21(13):2128-2137.70 窦德强,勒玲,陈英杰.人参的化学成分及药理活性的研究进展和展望[J].沈阳药科大学学报,1999,16(2):151-156.71 Zhou Xiaoming,Cao Yinglin,Dou Deqiang.Protective effect of ginsenoside Re against cerebral ischemia/reperfusion damage in Rats[J].Biol Pharm Bull,2006,29(12): 2502-2505.72 Dou DQ,Zhang YW,Zhang L,et al.The inhibitory effects of ginsenosides on protein tyrosine activation induced by hypoxia/reoxygenation in cultured human umbilical vein endothelial cells[J].Planta Medica,2001,67(1):19-23.73 Yu JL,Dou DQ,Chen XH,et al.Protopanaxatriol-type ginsenosides differentially modulate type 1 and type 2 cytokines production from murine splenocytes[J].Planta Medica,2005,71(3):202-207.74 Qiu Yingkun,Dou Deqiang,Cai Liping,et al.Dammarane-type saponins from Panax quinquefolium and their inhibition activity on human breast cancer MCF-7 cells[J].Fitoterapia,2009,80(4):219-222.